Article ID Journal Published Year Pages File Type
9312048 Urology 2005 5 Pages PDF
Abstract
HER2 overexpression and HER2 gene amplification were infrequent in our series. Thus, only a small number of patients with upper urinary tract TCC might benefit from HER2-targeted (Herceptin) cancer therapy.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , ,